Development and assessment of a community‐based screening tool for mental health disorders among people who inject drugs

Introduction The prevalence of mental health disorders among people who use drugs is high and well documented. This hard‐to‐reach population faces a very low awareness and access to mental health care, especially in developing countries. The objectives of this study were to design and assess a quick...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Drug and alcohol review 2022-03, Vol.41 (3), p.697-705
Hauptverfasser: Le, Sao M., Trouiller, Philippe, Duong, Thi H., Khuat, Thi H. O., Pham, Minh K., Vallo, Roselyne, Rapoud, Delphine, Quillet, Catherine, Nguyen, Thuy L., Nguyen, Quang D., Nham, Thi Tuyet T., Hoang, Thi G., Feelemyer, Jonathan, Vu, Hai V., Moles, Jean‐Pierre, Doan, Hong Q., Laureillard, Didier, Des Jarlais, Don C., Nagot, Nicolas, Michel, Laurent
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 705
container_issue 3
container_start_page 697
container_title Drug and alcohol review
container_volume 41
creator Le, Sao M.
Trouiller, Philippe
Duong, Thi H.
Khuat, Thi H. O.
Pham, Minh K.
Vallo, Roselyne
Rapoud, Delphine
Quillet, Catherine
Nguyen, Thuy L.
Nguyen, Quang D.
Nham, Thi Tuyet T.
Hoang, Thi G.
Feelemyer, Jonathan
Vu, Hai V.
Moles, Jean‐Pierre
Doan, Hong Q.
Laureillard, Didier
Des Jarlais, Don C.
Nagot, Nicolas
Michel, Laurent
description Introduction The prevalence of mental health disorders among people who use drugs is high and well documented. This hard‐to‐reach population faces a very low awareness and access to mental health care, especially in developing countries. The objectives of this study were to design and assess a quick screening tool (QST) that community‐based organisations (CBO) could routinely apply to a Vietnamese population of people who inject drugs (PWID), in order to refer them appropriately to mental health specialists. Methods We devised a tool that included nine questions covering anxiety, depression, suicide risk and psychotic symptomatology. Its use required no specific background and 2 h training. Specificity and sensitivity of the QST were assessed in a population of 418 PWID recruited via respondent driven sampling, using the Mini International Neuropsychiatric Interview questionnaire plus clinical evaluation as a reference standard. Acceptability was assessed using a self‐administered anonymous questionnaire submitted to all CBO members who used the QST. Results CBO members considered the QST easy to use, relevant and helpful to deal with mental health issues. Area under the curve for detection of any symptom using the QST was 0.770. The maximum sensitivity and specificity were reached with a cut‐off of 2 [sensitivity was 71.1% (95% confidence interval 62.4, 78.8), specificity was 75.9% (70.5, 80.7)]. Discussion and Conclusions The QST appeared to be both efficient and well accepted. Given the burden of mental health problems among hard‐to‐reach PWID in developing countries, community‐based screenings such as this one could be a particularly appropriate response.
doi_str_mv 10.1111/dar.13402
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10150937</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2638869129</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4782-657e5e9faf7afd55caea68081cd6e9b07b5d0b2c0ce8da74df6bbfbd5a7ab94d3</originalsourceid><addsrcrecordid>eNp1kcFu1DAURS1ERYfCgh9AllixSGsnsZOs0KgFijRSpQrW1rP9MskoiYOdTDWs-IR-Y78ET6cUqIQ3lu3j42tdQt5wdsrjOLPgT3mWs_QZWfBciiTLZPqcLFglqkSkmTwmL0PYMMZSIdIX5DjLi1IWQizIjwvcYufGHoeJwmAphIAh3C9dTYEa1_fz0E67u5-3GgJaGoxHHNphTSfnOlo7T_c4dLRB6KaG2jY4b9EHCr2L2Ihu7JDeNI62wwbNRK2f1-EVOaqhC_j6YT4h3z59_Hp-mayuPn85X64SE1OmiRQFCqxqqAuorRAGEGTJSm6sxEqzQgvLdGqYwdJCkdtaal1rK6AAXeU2OyEfDt5x1j1aE7N66NTo2x78Tjlo1b8nQ9uotdsqzrhgVVZEw_uDoXly73K5Uvs9lsmcCSa2PLLvHl7z7vuMYVIbN_shflClMitLWfG0-mM03oXgsX7Ucqb2narYqbrvNLJv_87_SP4uMQJnB-Cm7XD3f5O6WF4flL8AytWwJA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2638869129</pqid></control><display><type>article</type><title>Development and assessment of a community‐based screening tool for mental health disorders among people who inject drugs</title><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Sociological Abstracts</source><creator>Le, Sao M. ; Trouiller, Philippe ; Duong, Thi H. ; Khuat, Thi H. O. ; Pham, Minh K. ; Vallo, Roselyne ; Rapoud, Delphine ; Quillet, Catherine ; Nguyen, Thuy L. ; Nguyen, Quang D. ; Nham, Thi Tuyet T. ; Hoang, Thi G. ; Feelemyer, Jonathan ; Vu, Hai V. ; Moles, Jean‐Pierre ; Doan, Hong Q. ; Laureillard, Didier ; Des Jarlais, Don C. ; Nagot, Nicolas ; Michel, Laurent</creator><creatorcontrib>Le, Sao M. ; Trouiller, Philippe ; Duong, Thi H. ; Khuat, Thi H. O. ; Pham, Minh K. ; Vallo, Roselyne ; Rapoud, Delphine ; Quillet, Catherine ; Nguyen, Thuy L. ; Nguyen, Quang D. ; Nham, Thi Tuyet T. ; Hoang, Thi G. ; Feelemyer, Jonathan ; Vu, Hai V. ; Moles, Jean‐Pierre ; Doan, Hong Q. ; Laureillard, Didier ; Des Jarlais, Don C. ; Nagot, Nicolas ; Michel, Laurent ; DRIVE Study Team ; for the DRIVE Study Team</creatorcontrib><description>Introduction The prevalence of mental health disorders among people who use drugs is high and well documented. This hard‐to‐reach population faces a very low awareness and access to mental health care, especially in developing countries. The objectives of this study were to design and assess a quick screening tool (QST) that community‐based organisations (CBO) could routinely apply to a Vietnamese population of people who inject drugs (PWID), in order to refer them appropriately to mental health specialists. Methods We devised a tool that included nine questions covering anxiety, depression, suicide risk and psychotic symptomatology. Its use required no specific background and 2 h training. Specificity and sensitivity of the QST were assessed in a population of 418 PWID recruited via respondent driven sampling, using the Mini International Neuropsychiatric Interview questionnaire plus clinical evaluation as a reference standard. Acceptability was assessed using a self‐administered anonymous questionnaire submitted to all CBO members who used the QST. Results CBO members considered the QST easy to use, relevant and helpful to deal with mental health issues. Area under the curve for detection of any symptom using the QST was 0.770. The maximum sensitivity and specificity were reached with a cut‐off of 2 [sensitivity was 71.1% (95% confidence interval 62.4, 78.8), specificity was 75.9% (70.5, 80.7)]. Discussion and Conclusions The QST appeared to be both efficient and well accepted. Given the burden of mental health problems among hard‐to‐reach PWID in developing countries, community‐based screenings such as this one could be a particularly appropriate response.</description><identifier>ISSN: 0959-5236</identifier><identifier>EISSN: 1465-3362</identifier><identifier>DOI: 10.1111/dar.13402</identifier><identifier>PMID: 34786755</identifier><language>eng</language><publisher>Melbourne: John Wiley &amp; Sons Australia, Ltd</publisher><subject>Clinical assessment ; Community ; community setting ; Developing countries ; Drug Users ; Drugs ; Health problems ; Human health and pathology ; Humans ; LDCs ; Life Sciences ; Mass Screening ; Medical screening ; Mental depression ; Mental Disorders ; Mental Disorders - diagnosis ; Mental Disorders - epidemiology ; Mental Disorders - psychology ; Mental Health ; Mental health care ; Mental health services ; people who inject drugs ; Prevalence ; Psychological assessment ; Psychosis ; Questionnaires ; screening test ; Sensitivity training ; Specialists ; Substance Abuse, Intravenous ; Substance Abuse, Intravenous - epidemiology ; Substance Abuse, Intravenous - psychology ; Suicide ; Tests</subject><ispartof>Drug and alcohol review, 2022-03, Vol.41 (3), p.697-705</ispartof><rights>2021 Australasian Professional Society on Alcohol and other Drugs.</rights><rights>2022 Australasian Professional Society on Alcohol and other Drugs (APSAD)</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4782-657e5e9faf7afd55caea68081cd6e9b07b5d0b2c0ce8da74df6bbfbd5a7ab94d3</citedby><cites>FETCH-LOGICAL-c4782-657e5e9faf7afd55caea68081cd6e9b07b5d0b2c0ce8da74df6bbfbd5a7ab94d3</cites><orcidid>0000-0002-4068-8351 ; 0000-0001-6617-4992 ; 0000-0003-2974-3484 ; 0000-0002-2000-7838 ; 0000-0002-0104-9047 ; 0000-0002-2447-6754 ; 0000-0002-0157-8168 ; 0000-0002-6863-6350 ; 0000-0002-3493-2821</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fdar.13402$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fdar.13402$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,30976,33751,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34786755$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.umontpellier.fr/hal-03640505$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Le, Sao M.</creatorcontrib><creatorcontrib>Trouiller, Philippe</creatorcontrib><creatorcontrib>Duong, Thi H.</creatorcontrib><creatorcontrib>Khuat, Thi H. O.</creatorcontrib><creatorcontrib>Pham, Minh K.</creatorcontrib><creatorcontrib>Vallo, Roselyne</creatorcontrib><creatorcontrib>Rapoud, Delphine</creatorcontrib><creatorcontrib>Quillet, Catherine</creatorcontrib><creatorcontrib>Nguyen, Thuy L.</creatorcontrib><creatorcontrib>Nguyen, Quang D.</creatorcontrib><creatorcontrib>Nham, Thi Tuyet T.</creatorcontrib><creatorcontrib>Hoang, Thi G.</creatorcontrib><creatorcontrib>Feelemyer, Jonathan</creatorcontrib><creatorcontrib>Vu, Hai V.</creatorcontrib><creatorcontrib>Moles, Jean‐Pierre</creatorcontrib><creatorcontrib>Doan, Hong Q.</creatorcontrib><creatorcontrib>Laureillard, Didier</creatorcontrib><creatorcontrib>Des Jarlais, Don C.</creatorcontrib><creatorcontrib>Nagot, Nicolas</creatorcontrib><creatorcontrib>Michel, Laurent</creatorcontrib><creatorcontrib>DRIVE Study Team</creatorcontrib><creatorcontrib>for the DRIVE Study Team</creatorcontrib><title>Development and assessment of a community‐based screening tool for mental health disorders among people who inject drugs</title><title>Drug and alcohol review</title><addtitle>Drug Alcohol Rev</addtitle><description>Introduction The prevalence of mental health disorders among people who use drugs is high and well documented. This hard‐to‐reach population faces a very low awareness and access to mental health care, especially in developing countries. The objectives of this study were to design and assess a quick screening tool (QST) that community‐based organisations (CBO) could routinely apply to a Vietnamese population of people who inject drugs (PWID), in order to refer them appropriately to mental health specialists. Methods We devised a tool that included nine questions covering anxiety, depression, suicide risk and psychotic symptomatology. Its use required no specific background and 2 h training. Specificity and sensitivity of the QST were assessed in a population of 418 PWID recruited via respondent driven sampling, using the Mini International Neuropsychiatric Interview questionnaire plus clinical evaluation as a reference standard. Acceptability was assessed using a self‐administered anonymous questionnaire submitted to all CBO members who used the QST. Results CBO members considered the QST easy to use, relevant and helpful to deal with mental health issues. Area under the curve for detection of any symptom using the QST was 0.770. The maximum sensitivity and specificity were reached with a cut‐off of 2 [sensitivity was 71.1% (95% confidence interval 62.4, 78.8), specificity was 75.9% (70.5, 80.7)]. Discussion and Conclusions The QST appeared to be both efficient and well accepted. Given the burden of mental health problems among hard‐to‐reach PWID in developing countries, community‐based screenings such as this one could be a particularly appropriate response.</description><subject>Clinical assessment</subject><subject>Community</subject><subject>community setting</subject><subject>Developing countries</subject><subject>Drug Users</subject><subject>Drugs</subject><subject>Health problems</subject><subject>Human health and pathology</subject><subject>Humans</subject><subject>LDCs</subject><subject>Life Sciences</subject><subject>Mass Screening</subject><subject>Medical screening</subject><subject>Mental depression</subject><subject>Mental Disorders</subject><subject>Mental Disorders - diagnosis</subject><subject>Mental Disorders - epidemiology</subject><subject>Mental Disorders - psychology</subject><subject>Mental Health</subject><subject>Mental health care</subject><subject>Mental health services</subject><subject>people who inject drugs</subject><subject>Prevalence</subject><subject>Psychological assessment</subject><subject>Psychosis</subject><subject>Questionnaires</subject><subject>screening test</subject><subject>Sensitivity training</subject><subject>Specialists</subject><subject>Substance Abuse, Intravenous</subject><subject>Substance Abuse, Intravenous - epidemiology</subject><subject>Substance Abuse, Intravenous - psychology</subject><subject>Suicide</subject><subject>Tests</subject><issn>0959-5236</issn><issn>1465-3362</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><sourceid>BHHNA</sourceid><recordid>eNp1kcFu1DAURS1ERYfCgh9AllixSGsnsZOs0KgFijRSpQrW1rP9MskoiYOdTDWs-IR-Y78ET6cUqIQ3lu3j42tdQt5wdsrjOLPgT3mWs_QZWfBciiTLZPqcLFglqkSkmTwmL0PYMMZSIdIX5DjLi1IWQizIjwvcYufGHoeJwmAphIAh3C9dTYEa1_fz0E67u5-3GgJaGoxHHNphTSfnOlo7T_c4dLRB6KaG2jY4b9EHCr2L2Ihu7JDeNI62wwbNRK2f1-EVOaqhC_j6YT4h3z59_Hp-mayuPn85X64SE1OmiRQFCqxqqAuorRAGEGTJSm6sxEqzQgvLdGqYwdJCkdtaal1rK6AAXeU2OyEfDt5x1j1aE7N66NTo2x78Tjlo1b8nQ9uotdsqzrhgVVZEw_uDoXly73K5Uvs9lsmcCSa2PLLvHl7z7vuMYVIbN_shflClMitLWfG0-mM03oXgsX7Ucqb2narYqbrvNLJv_87_SP4uMQJnB-Cm7XD3f5O6WF4flL8AytWwJA</recordid><startdate>202203</startdate><enddate>202203</enddate><creator>Le, Sao M.</creator><creator>Trouiller, Philippe</creator><creator>Duong, Thi H.</creator><creator>Khuat, Thi H. O.</creator><creator>Pham, Minh K.</creator><creator>Vallo, Roselyne</creator><creator>Rapoud, Delphine</creator><creator>Quillet, Catherine</creator><creator>Nguyen, Thuy L.</creator><creator>Nguyen, Quang D.</creator><creator>Nham, Thi Tuyet T.</creator><creator>Hoang, Thi G.</creator><creator>Feelemyer, Jonathan</creator><creator>Vu, Hai V.</creator><creator>Moles, Jean‐Pierre</creator><creator>Doan, Hong Q.</creator><creator>Laureillard, Didier</creator><creator>Des Jarlais, Don C.</creator><creator>Nagot, Nicolas</creator><creator>Michel, Laurent</creator><general>John Wiley &amp; Sons Australia, Ltd</general><general>Wiley Subscription Services, Inc</general><general>Wiley</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QJ</scope><scope>7U3</scope><scope>BHHNA</scope><scope>1XC</scope><scope>VOOES</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-4068-8351</orcidid><orcidid>https://orcid.org/0000-0001-6617-4992</orcidid><orcidid>https://orcid.org/0000-0003-2974-3484</orcidid><orcidid>https://orcid.org/0000-0002-2000-7838</orcidid><orcidid>https://orcid.org/0000-0002-0104-9047</orcidid><orcidid>https://orcid.org/0000-0002-2447-6754</orcidid><orcidid>https://orcid.org/0000-0002-0157-8168</orcidid><orcidid>https://orcid.org/0000-0002-6863-6350</orcidid><orcidid>https://orcid.org/0000-0002-3493-2821</orcidid></search><sort><creationdate>202203</creationdate><title>Development and assessment of a community‐based screening tool for mental health disorders among people who inject drugs</title><author>Le, Sao M. ; Trouiller, Philippe ; Duong, Thi H. ; Khuat, Thi H. O. ; Pham, Minh K. ; Vallo, Roselyne ; Rapoud, Delphine ; Quillet, Catherine ; Nguyen, Thuy L. ; Nguyen, Quang D. ; Nham, Thi Tuyet T. ; Hoang, Thi G. ; Feelemyer, Jonathan ; Vu, Hai V. ; Moles, Jean‐Pierre ; Doan, Hong Q. ; Laureillard, Didier ; Des Jarlais, Don C. ; Nagot, Nicolas ; Michel, Laurent</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4782-657e5e9faf7afd55caea68081cd6e9b07b5d0b2c0ce8da74df6bbfbd5a7ab94d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Clinical assessment</topic><topic>Community</topic><topic>community setting</topic><topic>Developing countries</topic><topic>Drug Users</topic><topic>Drugs</topic><topic>Health problems</topic><topic>Human health and pathology</topic><topic>Humans</topic><topic>LDCs</topic><topic>Life Sciences</topic><topic>Mass Screening</topic><topic>Medical screening</topic><topic>Mental depression</topic><topic>Mental Disorders</topic><topic>Mental Disorders - diagnosis</topic><topic>Mental Disorders - epidemiology</topic><topic>Mental Disorders - psychology</topic><topic>Mental Health</topic><topic>Mental health care</topic><topic>Mental health services</topic><topic>people who inject drugs</topic><topic>Prevalence</topic><topic>Psychological assessment</topic><topic>Psychosis</topic><topic>Questionnaires</topic><topic>screening test</topic><topic>Sensitivity training</topic><topic>Specialists</topic><topic>Substance Abuse, Intravenous</topic><topic>Substance Abuse, Intravenous - epidemiology</topic><topic>Substance Abuse, Intravenous - psychology</topic><topic>Suicide</topic><topic>Tests</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Le, Sao M.</creatorcontrib><creatorcontrib>Trouiller, Philippe</creatorcontrib><creatorcontrib>Duong, Thi H.</creatorcontrib><creatorcontrib>Khuat, Thi H. O.</creatorcontrib><creatorcontrib>Pham, Minh K.</creatorcontrib><creatorcontrib>Vallo, Roselyne</creatorcontrib><creatorcontrib>Rapoud, Delphine</creatorcontrib><creatorcontrib>Quillet, Catherine</creatorcontrib><creatorcontrib>Nguyen, Thuy L.</creatorcontrib><creatorcontrib>Nguyen, Quang D.</creatorcontrib><creatorcontrib>Nham, Thi Tuyet T.</creatorcontrib><creatorcontrib>Hoang, Thi G.</creatorcontrib><creatorcontrib>Feelemyer, Jonathan</creatorcontrib><creatorcontrib>Vu, Hai V.</creatorcontrib><creatorcontrib>Moles, Jean‐Pierre</creatorcontrib><creatorcontrib>Doan, Hong Q.</creatorcontrib><creatorcontrib>Laureillard, Didier</creatorcontrib><creatorcontrib>Des Jarlais, Don C.</creatorcontrib><creatorcontrib>Nagot, Nicolas</creatorcontrib><creatorcontrib>Michel, Laurent</creatorcontrib><creatorcontrib>DRIVE Study Team</creatorcontrib><creatorcontrib>for the DRIVE Study Team</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><collection>Social Services Abstracts</collection><collection>Sociological Abstracts</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Drug and alcohol review</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Le, Sao M.</au><au>Trouiller, Philippe</au><au>Duong, Thi H.</au><au>Khuat, Thi H. O.</au><au>Pham, Minh K.</au><au>Vallo, Roselyne</au><au>Rapoud, Delphine</au><au>Quillet, Catherine</au><au>Nguyen, Thuy L.</au><au>Nguyen, Quang D.</au><au>Nham, Thi Tuyet T.</au><au>Hoang, Thi G.</au><au>Feelemyer, Jonathan</au><au>Vu, Hai V.</au><au>Moles, Jean‐Pierre</au><au>Doan, Hong Q.</au><au>Laureillard, Didier</au><au>Des Jarlais, Don C.</au><au>Nagot, Nicolas</au><au>Michel, Laurent</au><aucorp>DRIVE Study Team</aucorp><aucorp>for the DRIVE Study Team</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development and assessment of a community‐based screening tool for mental health disorders among people who inject drugs</atitle><jtitle>Drug and alcohol review</jtitle><addtitle>Drug Alcohol Rev</addtitle><date>2022-03</date><risdate>2022</risdate><volume>41</volume><issue>3</issue><spage>697</spage><epage>705</epage><pages>697-705</pages><issn>0959-5236</issn><eissn>1465-3362</eissn><abstract>Introduction The prevalence of mental health disorders among people who use drugs is high and well documented. This hard‐to‐reach population faces a very low awareness and access to mental health care, especially in developing countries. The objectives of this study were to design and assess a quick screening tool (QST) that community‐based organisations (CBO) could routinely apply to a Vietnamese population of people who inject drugs (PWID), in order to refer them appropriately to mental health specialists. Methods We devised a tool that included nine questions covering anxiety, depression, suicide risk and psychotic symptomatology. Its use required no specific background and 2 h training. Specificity and sensitivity of the QST were assessed in a population of 418 PWID recruited via respondent driven sampling, using the Mini International Neuropsychiatric Interview questionnaire plus clinical evaluation as a reference standard. Acceptability was assessed using a self‐administered anonymous questionnaire submitted to all CBO members who used the QST. Results CBO members considered the QST easy to use, relevant and helpful to deal with mental health issues. Area under the curve for detection of any symptom using the QST was 0.770. The maximum sensitivity and specificity were reached with a cut‐off of 2 [sensitivity was 71.1% (95% confidence interval 62.4, 78.8), specificity was 75.9% (70.5, 80.7)]. Discussion and Conclusions The QST appeared to be both efficient and well accepted. Given the burden of mental health problems among hard‐to‐reach PWID in developing countries, community‐based screenings such as this one could be a particularly appropriate response.</abstract><cop>Melbourne</cop><pub>John Wiley &amp; Sons Australia, Ltd</pub><pmid>34786755</pmid><doi>10.1111/dar.13402</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-4068-8351</orcidid><orcidid>https://orcid.org/0000-0001-6617-4992</orcidid><orcidid>https://orcid.org/0000-0003-2974-3484</orcidid><orcidid>https://orcid.org/0000-0002-2000-7838</orcidid><orcidid>https://orcid.org/0000-0002-0104-9047</orcidid><orcidid>https://orcid.org/0000-0002-2447-6754</orcidid><orcidid>https://orcid.org/0000-0002-0157-8168</orcidid><orcidid>https://orcid.org/0000-0002-6863-6350</orcidid><orcidid>https://orcid.org/0000-0002-3493-2821</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0959-5236
ispartof Drug and alcohol review, 2022-03, Vol.41 (3), p.697-705
issn 0959-5236
1465-3362
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10150937
source Applied Social Sciences Index & Abstracts (ASSIA); MEDLINE; Wiley Online Library Journals Frontfile Complete; Sociological Abstracts
subjects Clinical assessment
Community
community setting
Developing countries
Drug Users
Drugs
Health problems
Human health and pathology
Humans
LDCs
Life Sciences
Mass Screening
Medical screening
Mental depression
Mental Disorders
Mental Disorders - diagnosis
Mental Disorders - epidemiology
Mental Disorders - psychology
Mental Health
Mental health care
Mental health services
people who inject drugs
Prevalence
Psychological assessment
Psychosis
Questionnaires
screening test
Sensitivity training
Specialists
Substance Abuse, Intravenous
Substance Abuse, Intravenous - epidemiology
Substance Abuse, Intravenous - psychology
Suicide
Tests
title Development and assessment of a community‐based screening tool for mental health disorders among people who inject drugs
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T10%3A06%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20and%20assessment%20of%20a%20community%E2%80%90based%20screening%20tool%20for%20mental%20health%20disorders%20among%20people%20who%20inject%20drugs&rft.jtitle=Drug%20and%20alcohol%20review&rft.au=Le,%20Sao%20M.&rft.aucorp=DRIVE%20Study%20Team&rft.date=2022-03&rft.volume=41&rft.issue=3&rft.spage=697&rft.epage=705&rft.pages=697-705&rft.issn=0959-5236&rft.eissn=1465-3362&rft_id=info:doi/10.1111/dar.13402&rft_dat=%3Cproquest_pubme%3E2638869129%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2638869129&rft_id=info:pmid/34786755&rfr_iscdi=true